Meningococcal vaccines (MenACWY, MenB)

Meningococcal Vaccination

Pronounced (muh-nin-jeh-KOK-ul)

Vaccines can help prevent meningococcal disease, which is any type of illness caused by Neisseria meningitidis bacteria. There are 2 types of meningococcal vaccines available in the United States:

Meningococcal conjugate or MenACWY vaccines (Menactra®, Menveo®, and MenQuadfi®)
Serogroup B meningococcal or MenB vaccines (Bexsero®and Trumenba®)
All 11 to 12 year olds should get a MenACWY vaccine, with a booster dose at 16 years old. Teens and young adults (16 through 23 years old) also may get a MenB vaccine. CDC also recommends meningococcal vaccination for other children and adults who are at increased risk for meningococcal disease.

CDC recommends routine MenACWY vaccination for:

All preteens and teens at 11 to 12 years old with a booster dose at 16 years old
Children and adults at increased risk for meningococcal disease
CDC recommends routine MenB vaccination for:

People 10 years or older at increased risk for meningococcal disease

https://www.cdc.gov/vaccines/vpd/mening/index.html#:~:text=All%2011%20to%2012%20year,increased%20risk%20for%20meningococcal%20disease.